TheEdgeResearch
Home / Stocks / LEEEF

Leef Brands Inc. (LEEEF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.14 ▼ -1.38%
Market Cap
$29.4M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.31
52-Wk Range
0.005-0.287
CEO
Micah Anderson
Country
CA
Currency
USD

Leef Brands Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.14, down 1.38% on the session, giving a market capitalisation of $29.4M. On trailing twelve-month figures it carries a trailing P/E of -2.10, a net margin of -38.3%. Its beta of 0.31 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-2.10
Price / Sales
0.89
Price / Book
10.44
EV / EBITDA
-3.36
Gross margin
21.5%
Operating margin
-9.1%
Net margin
-38.3%
Return on equity
—
Debt / equity
2.87
Current ratio
2.24
Dividend yield
0.0%
Payout ratio
-1.2%
Company profile
Exchange
Other OTC
Employees
90
IPO date
2021-01-08
Headquarters
Vancouver, BC, CA
About Leef Brands Inc.

Leef Brands Inc. operates as a U.S.-based manufacturer of branded cannabis products. The company's operations are divided into two main divisions: Wholesale Concentrates and Retail. Its Wholesale Concentrates segment manages the complete production cycle for cannabis concentrates, encompassing cultivation (propagation, nursery, flowering canopy), post-harvest processing (drying, manufacturing), and distribution. Additionally, the Retail segment involves the ownership and direct operation of a cannabis retail store. Formerly known as Icanic Brands Company Inc., the organization rebranded to Leef Brands Inc. in December 2022. The company's corporate headquarters are located in Vancouver, Canada.

More research on LEEEF
LEEEF technical analysis LEEEF TheEdge Score Compare against peers
Open full interactive analysis & DCF →